glucagon has been researched along with clofibrate in 21 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (clofibrate) | Trials (clofibrate) | Recent Studies (post-2010) (clofibrate) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 3,859 | 314 | 131 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (90.48) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, M; Eaton, RP; George, S; Kaminsky, N; Schade, DS; Sivinski, J | 1 |
| Boberg, J; Hellsing, K; Lithell, H; Lundqvist, G; Vessby, B | 1 |
| Balasse, EO; Fery, F | 1 |
| Burr, IM; Greene, HL; O'Neill, JA; Slonim, AE | 1 |
| Eaton, RP; Lueker, R; Schade, DS | 1 |
| Drost, H; Gries, FA; Grüneklee, D; Korthaus, G | 1 |
| Assan, R; Crepaldi, G; Fedele, D; Muggeo, M; Tiengo, A | 1 |
| Eaton, RP; Schade, DS | 2 |
| Eacho, PI; Foxworthy, PS; Hoover, DM; White, SL | 1 |
| Crepaldi, G; Jemmolo, RM; Lirussi, F; Muraca, M; Nassuato, G; Okolicsanyi, L; Orlando, R; Strazzabosco, M | 1 |
| Brady, LJ; Brady, PS | 1 |
| Finnegan, I; Houslay, MD; Needham, L | 1 |
| Agius, L; Alberti, KG; Gerondaes, P | 1 |
| Eaton, RP | 1 |
| Tepperman, HM; Tepperman, J; Weis, AS | 1 |
| Sellers, E; Weser, JK | 1 |
| Crepaldi, G; Fedele, D; Muggeo, M; Tiengo, A | 1 |
| Capuzzi, DM; Lackman, RD; Pietra, GG | 1 |
| Linscheer, WG; Patel, DG; Raheja, KL | 1 |
| Gustafson, LA; Kuipers, F; Meijer, AJ; Romijn, JA; Sauerwein, HP; Wiegman, C | 1 |
2 review(s) available for glucagon and clofibrate
| Article | Year |
|---|---|
The effect of drugs on bile flow and composition. An overview.
Topics: Animals; Bile; Bile Acids and Salts; Cats; Chlorpromazine; Cholagogues and Choleretics; Cholesterol; Clofibrate; Colchicine; Cricetinae; Dehydrocholic Acid; Diuretics; Dogs; Enterohepatic Circulation; Estrogens; Glucagon; Guinea Pigs; Humans; Insulin; Liver; Macaca mulatta; Phospholipids; Rabbits; Rats; Rifampin; Rifamycins; Somatostatin; Theophylline; Ursodeoxycholic Acid | 1986 |
Drug interactions with coumarin anticoagulants. 2.
Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide | 1971 |
1 trial(s) available for glucagon and clofibrate
| Article | Year |
|---|---|
Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Diabetic Ketoacidosis; Fatty Acids, Nonesterified; Glucagon; Humans; Insulin; Ketone Bodies; Middle Aged; Triglycerides | 1978 |
18 other study(ies) available for glucagon and clofibrate
| Article | Year |
|---|---|
Increase of the lipoprotein-lipase activity in human skeletal muscle during clofibrate administration.
Topics: Adipose Tissue; Adult; Clofibrate; Female; Glucagon; Humans; Hyperlipidemias; Insulin; Lipoprotein Lipase; Male; Middle Aged; Muscles; Triglycerides | 1978 |
Influence of short-term administration of clofibrate on insulin and glucagon response to protein ingestion in man.
Topics: Adult; Blood Glucose; Clofibrate; Dietary Proteins; Female; Glucagon; Humans; Insulin; Lipids; Male; Meat; Time Factors | 1978 |
Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
Topics: Adolescent; Aspartate Aminotransferases; Blood Glucose; Child; Cholesterol; Clofibrate; Eating; Enteral Nutrition; Female; Glucagon; Glucose; Glycogen Storage Disease Type I; Growth Hormone; Humans; Hypoglycemia; Insulin; Lactates; Time Factors; Triglycerides; Uric Acid | 1976 |
Clofibrate-induced changes in glucagon and insulin secretion in patients with angiographically documented coronary artery disease.
Topics: Adult; Arginine; Clofibrate; Coronary Disease; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1977 |
[Effect of clofibrate therapy on the glucagon and insulin secretion as well as on the glucose tolerance in patients with type IV hyperlipoproteinemia].
Topics: Clofibrate; Glucagon; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Secretion | 1976 |
Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
Topics: Adult; Antigens; Arginine; Blood Glucose; Cholesterol; Clofibrate; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Secretion; Middle Aged; Time Factors; Triglycerides | 1975 |
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability.
Topics: Adult; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Ketone Bodies; Male; Triglycerides | 1975 |
Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes.
Topics: Acetophenones; Animals; Autacoids; Azoles; Bezafibrate; Cells, Cultured; Clofibrate; Clofibric Acid; Dexamethasone; Dogs; Dose-Response Relationship, Drug; Female; Fibric Acids; Glucagon; Hypolipidemic Agents; In Vitro Techniques; Liver; Male; Microbodies; Microscopy, Electron; NAD; Oxidation-Reduction; Rats; Tetrazoles; Tyrosine Transaminase | 1990 |
Effects of clofibrate and acetylsalicylic acid on hepatic carnitine palmitoyltransferase synthesis.
Topics: Acyltransferases; Animals; Aspirin; Carnitine O-Palmitoyltransferase; Clofibrate; Diethylhexyl Phthalate; Glucagon; Liver; Male; Rats; Rats, Inbred Strains; RNA, Messenger; Transcription, Genetic | 1989 |
Adenylate cyclase and a fatty acid spin probe detect changes in plasma membrane lipid phase separations induced by dietary manipulation of the cholesterol:phospholipid ratio.
Topics: Adenylyl Cyclases; Animals; Cell Membrane; Cholesterol; Cholesterol, Dietary; Clofibrate; Electron Spin Resonance Spectroscopy; Fluorides; Glucagon; Liver; Male; Membrane Fluidity; Membrane Lipids; Phospholipids; Rats; Rats, Inbred Strains; Spin Labels | 1985 |
Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine.
Topics: Animals; Bezafibrate; Carnitine; Carnitine O-Acetyltransferase; Carnitine O-Palmitoyltransferase; Cells, Cultured; Clofibrate; Clofibric Acid; Fatty Acids; Fibric Acids; Glucagon; Humans; Hypolipidemic Agents; Insulin; Liver; Male; Rats; Rats, Inbred Strains | 1988 |
Effect of clofibrate on arginine-induced insulin and glucagon secretion.
Topics: Animals; Arginine; Blood Glucose; Blood Proteins; Cholesterol; Clofibrate; Fatty Acids, Nonesterified; Glucagon; Injections, Intraperitoneal; Injections, Subcutaneous; Insulin; Lipoproteins, VLDL; Male; Rats; Stimulation, Chemical; Triglycerides | 1973 |
Effects of p-chlorophenoxyisobutyrate (CPIB) on serum insulin levels, insulin sensitivity, and adipose tissue cyclic AMP concentration.
Topics: Adipose Tissue; Animals; Blood Glucose; Carbon Isotopes; Clofibrate; Cyclic AMP; Epinephrine; Glucagon; Glucose; Insulin; Male; Rats | 1973 |
Growth hormone secretion in primary endogenous hypertriglyceridemia.
Topics: Adult; Arginine; Blood Glucose; Body Weight; Clofibrate; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Hyperlipidemias; Insulin; Male; Middle Aged; Radioimmunoassay; Triglycerides | 1973 |
Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
Topics: Adult; Arginine; Blood Glucose; Clofibrate; Depression, Chemical; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Stimulation, Chemical; Triglycerides | 1974 |
Stimulated secretion of esterified lipids and VLDL by perifused hepatocytes.
Topics: Animals; Clofibrate; Cytological Techniques; Epinephrine; Glucagon; Glucose; In Vitro Techniques; Lipoproteins, VLDL; Liver; Male; Palmitates; Rats; Stimulation, Chemical; Triglycerides | 1981 |
Hypolipidemic and glycogenolytic effect of clofibrate (CPIB) in hypothyroid mice: role of insulin and glucagon.
Topics: Animals; Clofibrate; Glucagon; Glycogen; Hypolipidemic Agents; Hypothyroidism; Insulin; Lipid Metabolism; Liver Glycogen; Male; Mice; Organ Size; Propylthiouracil | 1982 |
Clofibrate improves glucose tolerance in fat-fed rats but decreases hepatic glucose consumption capacity.
Topics: Animal Feed; Animals; Blood Glucose; Body Temperature; Clofibrate; Dietary Fats; Eating; Fatty Acids, Nonesterified; Glucagon; Glucokinase; Glucose Intolerance; Glucose-6-Phosphatase; Glycogen; Hypolipidemic Agents; Insulin; Liver; Male; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Weight Gain | 2002 |